A Randomized, Double Blind Placebo Controlled Study Evaluating teh Efficacy and Safety of Copanlisib in Combination with Rituximab In Relapsed Indolent B-Cell NonHodgkins Lymphoma (CHRONOS-3)
A Randomized, Double Blind Placebo Controlled Study Evaluating teh Efficacy and Safety of Copanlisib in Combination with Rituximab In Relapsed Indolent B-Cell NonHodgkins Lymphoma (CHRONOS-3)
Trial Category:
Lymphoma
Phase
III
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
